Delivery Order SPE2DB22D1106-SPE2DB23FEYE1
Award Date 9/7/23
Potential Completion Date 9/28/23
Potential Value $30K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,490.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE 75 MG. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is September 6 through September 27, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this delivery order supports DLA's mission to provide critical...
- The Defense Logistics Agency awarded a $15,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE 75 MG. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the capsules to its facility in Conshohocken, Pennsylvania by mid-October 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $22,470.51 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 21 capsules of the drug IBRANCE at 75mg to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one month period concluding in mid-September 2023. As a top pharmaceutical distributor, Amerisourcebergen will leverage its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,247.92 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count packaging) under a firm fixed price contract. The contract was competitively awarded without a set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.82 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count units). This firm fixed-price delivery order, issued on November 18, 2025, with completion targeted for December 10, 2025, represents a non-competitive set-aside award supporting federal pharmaceutical procurement needs. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,682.66 to AmerisourceBergen Drug Corp for 21 capsules of Ibrance 75 mg on December 8, 2025, with a completion date of December 30, 2025. This firm fixed-price delivery order, issued without set-aside status, represents a competitive award to the pharmaceutical distributor for brand-name oncology medication. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $22,463.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE 75 MG. The place of performance is Conshohocken, Pennsylvania and the period of performance is July 27, 2023 through August 17, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for the cancer treatment drug IBRANCE supports the Agency's mission to provide critical...
- The Defense Logistics Agency awarded a $15,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE (palbociclib) to support the agency's medical supply needs. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will deliver the ordered products from its facility in Conshohocken, Pennsylvania to an unspecified location by August 2, 2023 to fulfill requirements under the...
- The Defense Logistics Agency awarded a $7,488.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 mg IBRANCE tablets. Under this order, Amerisourcebergen will deliver 7 boxes of the cancer treatment drug to a facility in Conshohocken, Pennsylvania by October 19th to support the DLA's medical supply chain operations. As a top pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor contracts to provide...
- The Defense Logistics Agency awarded a $37,444 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE 100 MG. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a period of three weeks concluding in mid-September. No set aside designation or subcontractors were...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEYE1Delivery Order
The Defense Logistics Agency awarded a $30,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceuticals. Under this order, Amerisourcebergen will supply 21 capsules of the cancer drug Ibrance at 100mg per capsule to fulfill DLA requirements. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding on September 28, 2023. No subcontractors or set aside designations were identified. This order is consistent with DLA's mission to provide medical supplies and pharmaceuticals to support military treatment facilities worldwide.
Generated 12/18/23, 2:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.0k | 9/7/23 |